DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells (Q82267564)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Bjarne Bogen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Inger Sandlie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Agnete B Fredriksen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

18 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

776-785

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

DNA immunization--a new chance in vaccine research?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Gene transfer into muscle by electroporation in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Myeloma proteins as tumor-specific transplantation antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Idiotypic DNA vaccines against B-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

DNA immunization induces protective immunity against B-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Monoclonal antibodies produced by muscle after plasmid injection and electroporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

High In Vivo Production of a Model Monoclonal Antibody on Adenoviral Gene Transfer

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

inferred from DOI database lookup

7 January 2021

based on heuristic

Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

DNA transfection of mononuclear cells in muscle tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

DNA-based immunization by in vivo transfection of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

B cells acquire antigen from target cells after synapse formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

IgM secretory tailpiece drives multimerisation of bivalent scFv fragments in eukaryotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.10.019

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2005.10.019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16414309%20AND%20SRC:MED&resulttype=core&format=json